UMOJA-BIOPHARMA.COM: Keyword Density Checker

Total words: 1041 | 2-word phrases: 264 | 3-word phrases: 294 | 4-word phrases: 305

PAGE INFO

Title	Try to keep the title under 60 characters (15 characters) Umoja Biopharma
Description	Try to keep the meta description between 50 - 160 characters (128 characters) Umoja Biopharma pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells and generate lasting remission.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (71 characters) Pioneering the future of immunotherapy by reprogramming T cells in vivo

#	Keyword	Frequency	Density
1	our company	6	2.27%
2	menu toggle	6	2.27%
3	umoja biopharma	5	1.89%
4	our science	5	1.89%
5	in the	5	1.89%
6	partnerships our	4	1.52%
7	white papers	4	1.52%
8	media blog	4	1.52%
9	the media	4	1.52%
10	releases in	4	1.52%
11	press releases	4	1.52%
12	manufacturing partnerships	4	1.52%
13	biopharma announce	3	1.14%
14	science menu	3	1.14%
15	toggle overview	3	1.14%
16	our pipeline	3	1.14%
17	careers contact	3	1.14%
18	blog white	3	1.14%
19	pipeline newsresources	3	1.14%
20	2024 umoja	3	1.14%

#	Keyword	Frequency	Density
1	manufacturing partnerships our	4	1.36%
2	in the media	4	1.36%
3	press releases in	4	1.36%
4	the media blog	4	1.36%
5	releases in the	4	1.36%
6	2024 umoja biopharma	3	1.02%
7	umoja biopharma announce	3	1.02%
8	blog white papers	3	1.02%
9	media blog white	3	1.02%
10	our science menu	3	1.02%
11	umoja biopharma announces	2	0.68%
12	menu toggle overview	2	0.68%
13	tumors and hematologic	2	0.68%
14	the future of	2	0.68%
15	future of immunotherapy	2	0.68%
16	company our science	2	0.68%
17	our company our	2	0.68%
18	presentations careers contact	2	0.68%
19	science menu toggle	2	0.68%
20	toggle overview manufacturing	2	0.68%
21	overview manufacturing partnerships	2	0.68%
22	toggle press releases	2	0.68%
23	menu toggle press	2	0.68%
24	newsresources menu toggle	2	0.68%
25	pipeline newsresources menu	2	0.68%
26	our pipeline newsresources	2	0.68%
27	partnerships our pipeline	2	0.68%
28	treat solid tumors	2	0.68%
29	solid tumors and	2	0.68%
30	policy transparency in	2	0.68%

#	Keyword	Frequency	Density
1	in the media blog	4	1.31%
2	releases in the media	4	1.31%
3	press releases in the	4	1.31%
4	media blog white papers	3	0.98%
5	the media blog white	3	0.98%
6	science menu toggle overview	2	0.66%
7	toggle press releases in	2	0.66%
8	our science menu toggle	2	0.66%
9	solid tumors and hematologic	2	0.66%
10	our company our science	2	0.66%
11	treat solid tumors and	2	0.66%
12	the future of immunotherapy	2	0.66%
13	menu toggle press releases	2	0.66%
14	2024 umoja biopharma announces	2	0.66%
15	pipeline newsresources menu toggle	2	0.66%
16	partnerships our pipeline newsresources	2	0.66%
17	manufacturing partnerships our pipeline	2	0.66%
18	toggle overview manufacturing partnerships	2	0.66%
19	overview manufacturing partnerships our	2	0.66%
20	resourcescareers callout newsresources we	1	0.33%
21	therapy platform works in	1	0.33%
22	platform works in vivo	1	0.33%
23	works in vivo to	1	0.33%
24	tumors and hematologic malignancies	1	0.33%
25	and hematologic malignancies at	1	0.33%
26	hematologic malignancies at every	1	0.33%
27	at every stage see	1	0.33%
28	malignancies at every stage	1	0.33%
29	labpipeline callout scientist in	1	0.33%
30	every stage see our	1	0.33%
31	pipeline scientist in labpipeline	1	0.33%
32	scientist in labpipeline callout	1	0.33%
33	in labpipeline callout scientist	1	0.33%
34	tcell gene therapy platform	1	0.33%
35	callout scientist in labnews	1	0.33%
36	gene therapy platform works	1	0.33%
37	latest news june 13	1	0.33%
38	car tcell gene therapy	1	0.33%
39	our science our scalable	1	0.33%
40	the patient’s body to	1	0.33%

#	URL	Whois	Check
1	https://premera.sapphiremrfhub.com/	Whois	sapphiremrfhub.com
2	https://www.linkedin.com/company/umoja-biopharma/	Whois	linkedin.com
3	https://twitter.com/UmojaBiopharma	Whois	twitter.com
4	https://premera.sapphiremrfhub.com/	Whois	sapphiremrfhub.com